FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -41,258.8% | -60,283.7% | -75,934.1% | -191.1% | -7,697.2% | – | – | – | – | – | – | |
| 454.9% | 520.4% | 712.2% | 3.5% | 30.6% | – | – | – | – | – | – | |
| – | – | 10,856.1% | 38.1% | 99.2% | – | – | – | – | – | – | |
| – | – | – | 0.9% | 100.0% | – | – | – | – | – | – | |
| 1,464.7% | 3,816.3% | 6,143.9% | 33.7% | 3,475.0% | – | – | – | – | – | – | |
| 452.9% | 1,071.4% | 1,597.6% | 10.9% | 450.0% | – | – | – | – | – | – | |
| -48,878.4% | 50,136.7% | -67,578.0% | -23.2% | -450.0% | – | – | – | – | – | – | |
| 65,160.8% | 6,906.1% | 217.1% | 160.0% | 22,908.3% | – | – | – | – | – | – | |
| – | – | – | 3.5% | – | – | – | – | – | – | – | |
| 97,874.5% | 4,759.2% | 217,714.6% | 241.4% | 13,488.9% | – | – | – | – | – | – | |
| 7,737.3% | -5,387.8% | 74,202.4% | 27.1% | -94,094.4% | – | – | – | – | – | – | |
| -41,711.8% | -61,355.1% | -77,531.7% | -202.0% | -8,147.2% | – | – | – | – | – | – |
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.